Member Info for Livedataaccount

Timster, the self elected Avacta Policeman.

It is OK to look for negatives on an investment.

Wyndrum, dont take it to heart. Readers want to be reassured. Ie £20 by xmas type posts get the most ticks. And anything challenging Avacta gets attacked. Todays announcement is good news and shows Avactas ambition for monetising the platform. Now they need to do some deals to keep the show on the road.

Jive.

Avactas current financing is with susq. (heights capital)

https://en.m.wikipedia.org/wiki/Susquehanna_International_Group

See. Controversies and legal actions on the wiki page

Much rather Avacta did a deal wIth BP

Why do you have to speak in these ridiculous riddles? Just spit it out

Is it really so bad to ask about financing?

Lots of aggresion when the subject is brought up.

Blimey, timster, i just saw your post count. Over 18000. Most related to Avacta.

Serious question. What do you expect for the next financing round for Avacta?

I have said for months i would be happy with 4 quid. I guess it depends on your timescale.

People seem to refuse to look at how Avacta are going to finance this and build the company.

Then why is the market pricing in equity financing?

It sure isnt anticipating a blockbuster deal.

Why did the CEO say it was difficult to sort

financing at the level Avacta was valued?

Juat saying it as I see it.

Im not Wyns biggest fan, but I imagine he speaks for the SILENT majority

The share price is does the talking and seems to be expecting some sort of equity financing.

Ok

I assume they wouldnt be screening if the FDA havent signed off the study?

Dr Coughlin said they are screening.

So, that means its already started.

Long winded, but not drivel. Wyndrum makes a good poont about dx.

AS spent a good chunk of the fundraise on 2 companies only months later to say they may be spun off to finance therapeutics. Maybe just AS musing, but very odd all the same.

Icecool.

'a license deal for the platform could appear at any time'

What value do you put on sucha deal that could appear at any time?

The market is pricing in an equity fund raise. And by AS comments so is he. Eg, his comments at science day about being overvalued amd raisikf capital

Why would any commercially savvy CEO state the company is toppy.

Greed and self interest?

Its a plc not a charity.

Proably sinking in that 1a isnt finished.

Is arm 2 of phase 2 approved?

Will they really be able start phase 2 in 2024?

Financing?

All very relevent questions

Because the market doesnt have faith in Dr. Smiths medium term financing.

Come on Alan, show us a deal.

I would like to hear opinions on what people think avacta's next financing arrangement will be.

It's going to have to be arranged Q1/2 next year I would have thought.

Dr Smith has stated he will keep AVA6000 in house and an look to partner Precision for others to develop their own drugs.

Personally, I think its too early to partner and companies will at least wait for data from the 2 weekly study before committing.

This leaves selling the diagnostics business (how quickly could that be arranged?).

Or another Heights capital type fundraise

This is the reason for lack of share price rise imo

I recommend every investor to watch it again if they havent already. Amazing presentation.

I am no expert on clinical data releases, whatsoever.

But was yesterdays presentation quite light on data? It felt more of a sales pitch to me.

But like i say, no expert.

More than happy for Dr Coughlin to speak on behalf of the company going foward.

She is in a different league when it comes to pibloc speaking. Gave Avacta the feel of being a corporate enterprise.